Slide 1: The Trendlines Group Financial highlights FY2017
The Trendlines Group Financial highlights FY2017 Steve Rhodes Todd Dollinger Gabi Heller Chairman and CEO Chairman and CEO Chief Financial Officer February 2018 SGX:42T OTCQX: TRNLY
Slide 2: Agenda
Agenda • Corporate highlights • Financial highlights • Post year-end developments 2
Slide 3: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 4: Corporate highlights
Corporate highlights
Slide 5: 10 years of portfolio value expansion
10 years of portfolio value expansion US$ millions Portfolio value with exit proceeds 140 120 Portfolio value* 100 Cumulative exit proceeds 80 60 40 20 0 30.12.08 30.12.09 30.12.10 30.12.11 31.12.12 31.12.13 31.12.14 31.12.15 31.12.16 31.12.17 *Portfolio value includes the fair value of investments
Slide 6: Key financial developments FY2017
Key financial developments FY2017 31 December 31 December Change % Change 2017 2016 Portfolio value US$ 96.8 million US$ 83.7 million + US$ 13.1 million + 16% Net gain/loss US$ 3.9 million (US$ 6.6 million) + US$ 10.5 million N/A Book value US$ 92.2 million US$ 78.2 million + US$ 14.0 million + 18%
Slide 7: Key corporate developments FY2017
Key corporate developments FY2017 • Trendlines Medical Singapore Pte. Ltd. launched and invested in its first company • New strategic partnership established with Haier Hai Chuanghui Incubator and Ventures • Trendlines raised US$10.3 million of gross proceeds in new shares placement • Trendlines Lab
Slide 8: Key portfolio company developments FY 2017
Key portfolio company developments FY 2017 • Nine new companies established • Eight in Israel; one in Singapore • New company (IBI-Ag Ltd.) established under Bayer Trendlines Ag Innovation Fund • 15 portfolio companies raised over US$20 million in follow-on investments – 4 from strategic partners •
Slide 9: 10 companies to watch
10 companies to watch* • ApiFix Ltd. • BioFishency Ltd. • EdenShield Ltd. • Fidmi Medical Ltd. • Gordian Surgical Ltd. • Leviticus Cardio Ltd. • MemTech Ltd. • Saturas Ltd. • STS Medical Ltd. • Vensica Medical Ltd. *Updated report issued: 18 January 2018 9
Slide 10: Q4 highlights from the "10 companies to watch" report
Q4 highlights from the “10 companies to watch” report • ApiFix Ltd. announced new leadership and establishment of US presence; has completed >185 surgeries • BioFishency Ltd. reached US$550,000 in sales in 2017 • EdenShield Ltd. achieved US$450,000 in sales in 2017 • Gordian Surgical Ltd. has comple
Slide 11: Financial highlights
Financial highlights
Slide 12: Consolidated condensed report of income
Consolidated condensed report of income 12
Slide 13: Key value components
Key value components Change in portfolio value during year Balance sheet (US$ millions) 20.4 (3.8) (7.8) (5.3) 16.4 (13.8) 4.5 (1.4) 83.7 96.8 92.9 Net portfolio Investments and Fair value Fair value Net portfolio Cash, short-term Fair value of Deferred Deferred tax** Payables & Total equity value 3
Slide 14: Post year-end developments
Post year-end developments
Slide 15: Post year-end developments
Post year-end developments • Product launch by Most Valuable Portfolio Company (“MVP”) on schedule for 2018 • Trendlines Medical Singapore Pte. Ltd. and K2 Global Pte. Ltd. to participate in a government-backed SGD100 million start-up program by SPRING SEEDS Capital Pte. Ltd. • Trendlines Labs conti
Slide 16: AgriVest 2018
AgriVest 2018 8 May 2018 | Tel Aviv, Israel www.agrivestisrael.com 14-Dec-17 16
Slide 17: Contact details
SGX: 42T Steve Rhodes, Chairman & CEO OTCQX: TRNLY steve@trendlines.com Todd Dollinger, Chairman & CEO +972.72.260.7000 todd@trendlines.com www.trendlines.com Gabi Heller, Chief Financial Officer gabi@trendlines.com 22 February 2018
Slide 18: SGX announcement: Financial Statements and Related Announcement
Issuer/Manager THE TRENDLINES GROUP LTD. Securities THE TRENDLINES GROUP LTD. – IL0011328858 – 42T Stapled Security No Announcement Title Financial Statements and Related Announcement Date & Time of Broadcast 21-Feb-2018 22:09:45 Status New Announcement Sub Title Full Yearly Results Announcement Ref